Isosupra Lidose (Isotretinoin)

Isotretinoin acts by binding to nuclear retinoic acid receptors (RAR) and retinoid X receptors (RXR) in skin cells, especially sebaceous glands. This binding modifies gene expression, leading to decreased sebaceous gland size, reduced sebum output, normalization of follicular keratinization, and anti‑inflammatory effects, all of which target the underlying mechanisms of severe acne.

The specific dose of Isosupra Lidose is determined by the prescribing clinician based on the patient’s weight, severity of acne, and individual response. Dosing regimens are individualized, and the prescriber will provide detailed instructions that should be followed precisely.

Isotretinoin is classified as pregnancy category X because it is highly teratogenic and can cause severe birth defects. It must not be used by pregnant women, and effective contraception is required for women of child‑bearing potential. Use during breastfeeding is also contraindicated, as the drug can be excreted in breast milk and may harm the infant.

To order Isosupra Lidose, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team will provide pricing, availability, shipping details and any necessary import documentation.

Isosupra Lidose (isotretinoin) is a systemic retinoid that offers a disease‑modifying effect, unlike many oral antibiotics or topical agents that only control symptoms. Compared with other retinoids such as acitretin, isotretinoin has a more favorable safety profile for acne and is the only oral medication proven to achieve long‑term remission after a finite course.

Isosupra Lidose should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Isosupra Lidose is taken orally, usually with a meal or a glass of milk to reduce gastrointestinal irritation. The tablets (or capsules) should be swallowed whole with water and not crushed or chewed. Patients should follow the dosing schedule prescribed by their healthcare provider.

The most serious risks include teratogenicity (birth defects if exposure occurs during pregnancy), severe depression or suicidal thoughts, liver toxicity indicated by elevated transaminases, and significant elevations in blood lipids that may lead to pancreatitis. Prompt medical attention is required if any of these events are suspected.

Isosupra Lidose should not be used by pregnant or nursing women, individuals with known hypersensitivity to isotretinoin or other retinoids, patients with uncontrolled liver disease, severe hyperlipidaemia, or those taking contraindicated medications such as tetracyclines or high‑dose vitamin A supplements.